{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:04:51Z","timestamp":1791644691116,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"NYU Clinical and Translational Science Institute","award":["NIH\/NCATS 1UL1 TR001445"],"award-info":[{"award-number":["NIH\/NCATS 1UL1 TR001445"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00408-020-00387-6","type":"journal-article","created":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T12:02:31Z","timestamp":1599307351000},"page":"811-819","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of Clinical Measures Among Interstitial Lung Disease (ILD) Patients with Usual Interstitial Pneumonia (UIP) Patterns on High-Resolution Computed Tomography"],"prefix":"10.1007","volume":"198","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5244-5234","authenticated-orcid":false,"given":"Charlisa D.","family":"Gibson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Deshwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith D.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rany","family":"Condos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,5]]},"reference":[{"issue":"6","key":"387_CR1","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA et al (2011) An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183(6):788\u2013824","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"387_CR2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1513\/pats.200601-005TK","volume":"3","author":"DS Kim","year":"2006","unstructured":"Kim DS, Collard HR, King TE Jr (2006) Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc 3(4):285\u2013292","journal-title":"Proc Am Thorac Soc"},{"issue":"7","key":"387_CR3","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1164\/rccm.200703-463PP","volume":"176","author":"HR Collard","year":"2007","unstructured":"Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE Jr, Lasky JA, Loyd JE, Noth I, Olman MA et al (2007) Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 176(7):636\u2013643","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"387_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1164\/rccm.201602-0402OC","volume":"195","author":"G Raghu","year":"2017","unstructured":"Raghu G, Wells AU, Nicholson AG, Richeldi L, Flaherty KR, Le Maulf F, Stowasser S, Schlenker-Herceg R, Hansell DM (2017) Effect of nintedanib in subgroups of idiopathic pulmonary fibrosis by diagnostic criteria. Am J Respir Crit Care Med 195(1):78\u201385","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"387_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1183\/13993003.00026-2015","volume":"47","author":"PW Noble","year":"2016","unstructured":"Noble PW, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, Fishman RS, Glaspole I, Glassberg MK, Lancaster L et al (2016) Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials. Eur Respir J 47(1):243\u2013253","journal-title":"Eur Respir J"},{"issue":"2","key":"387_CR6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1164\/rccm.201902-0456OC","volume":"200","author":"TM Dempsey","year":"2019","unstructured":"Dempsey TM, Sangaralingham LR, Yao X, Sanghavi D, Shah ND, Limper AH (2019) Clinical effectiveness of antifibrotic medications for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 200(2):168\u2013174","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"387_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S2213-2600(16)30326-5","volume":"5","author":"SD Nathan","year":"2017","unstructured":"Nathan SD, Albera C, Bradford WZ, Costabel U, Glaspole I, Glassberg MK, Kardatzke DR, Daigl M, Kirchgaessler KU, Lancaster LH et al (2017) Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis. Lancet Respir Med 5(1):33\u201341","journal-title":"Lancet Respir Med"},{"key":"387_CR8","first-page":"43s","volume":"32","author":"RM du Bois","year":"2001","unstructured":"du Bois RM, Wells AU (2001) Cryptogenic fibrosing alveolitis\/idiopathic pulmonary fibrosis. Eur Respir J Suppl 32:43s\u201355s","journal-title":"Eur Respir J Suppl"},{"issue":"2","key":"387_CR9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S2213-2600(17)30433-2","volume":"6","author":"DA Lynch","year":"2018","unstructured":"Lynch DA, Sverzellati N, Travis WD, Brown KK, Colby TV, Galvin JR, Goldin JG, Hansell DM, Inoue Y, Johkoh T et al (2018) Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. Lancet Respir Med 6(2):138\u2013153","journal-title":"Lancet Respir Med"},{"issue":"3","key":"387_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.rmed.2015.01.009","volume":"109","author":"Y Kondoh","year":"2015","unstructured":"Kondoh Y, Johkoh T, Fukuoka J, Arakawa H, Tanaka T, Watanabe N, Sakamoto K, Kataoka K, Kimura T, Taniguchi H (2015) Broader criteria of undifferentiated connective tissue disease in idiopathic interstitial pneumonias. Respir Med 109(3):389\u2013396","journal-title":"Respir Med"},{"issue":"3","key":"387_CR11","doi-asserted-by":"publisher","first-page":"e0193608","DOI":"10.1371\/journal.pone.0193608","volume":"13","author":"Y Kondoh","year":"2018","unstructured":"Kondoh Y, Taniguchi H, Kataoka K, Furukawa T, Shintani A, Fujisawa T, Suda T, Arita M, Baba T, Ichikado K et al (2018) Clinical spectrum and prognostic factors of possible UIP pattern on high-resolution CT in patients who underwent surgical lung biopsy. PLoS ONE 13(3):e0193608","journal-title":"PLoS ONE"},{"issue":"2","key":"387_CR12","first-page":"129","volume":"32","author":"K Sugino","year":"2015","unstructured":"Sugino K, Nakamura Y, Ito T, Isshiki T, Sakamoto S, Homma S (2015) Comparison of clinical characteristics and outcomes between combined pulmonary fibrosis and emphysema associated with usual interstitial pneumonia pattern and non-usual interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 32(2):129\u2013137","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"2","key":"387_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1164\/rccm.201809-1652OC","volume":"200","author":"RK Putman","year":"2019","unstructured":"Putman RK, Gudmundsson G, Axelsson GT, Hida T, Honda O, Araki T, Yanagawa M, Nishino M, Miller ER, Eiriksdottir G et al (2019) Imaging patterns are associated with interstitial lung abnormality progression and mortality. Am J Respir Crit Care Med 200(2):175\u2013183","journal-title":"Am J Respir Crit Care Med"},{"key":"387_CR14","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02465-2018","author":"J Fukihara","year":"2020","unstructured":"Fukihara J, Kondoh Y, Brown KK, Kimura T, Kataoka K, Matsuda T, Yamano Y, Suzuki A, Furukawa T, Sumikawa H et al (2020) Probable UIP pattern on chest CT: is it sufficient for a diagnosis of IPF? Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.02465-2018","journal-title":"Eur Respir J"},{"issue":"21","key":"387_CR15","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","volume":"366","author":"Idiopathic Pulmonary Fibrosis Clinical Research N, Raghu G, Anstrom KJ, King TE Jr, Lasky JA, Martinez FJ","year":"2012","unstructured":"Idiopathic Pulmonary Fibrosis Clinical Research N, Raghu G, Anstrom KJ, King TE Jr, Lasky JA, Martinez FJ (2012) Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 366(21):1968\u20131977","journal-title":"N Engl J Med"},{"issue":"3","key":"387_CR16","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1183\/09031936.05.00071004","volume":"25","author":"Y Kondoh","year":"2005","unstructured":"Kondoh Y, Taniguchi H, Yokoi T, Nishiyama O, Ohishi T, Kato T, Suzuki K, Suzuki R (2005) Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia. Eur Respir J 25(3):528\u2013533","journal-title":"Eur Respir J"},{"issue":"2","key":"387_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P et al (2005) Standardisation of spirometry. Eur Respir J 26(2):319\u2013338","journal-title":"Eur Respir J"},{"issue":"1","key":"387_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","volume":"159","author":"JL Hankinson","year":"1999","unstructured":"Hankinson JL, Odencrantz JR, Fedan KB (1999) Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159(1):179\u2013187","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"387_CR19","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1183\/09031936.05.00035205","volume":"26","author":"R Pellegrino","year":"2005","unstructured":"Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26(5):948\u2013968","journal-title":"Eur Respir J"},{"issue":"3","key":"387_CR20","doi-asserted-by":"publisher","first-page":"e0151425","DOI":"10.1371\/journal.pone.0151425","volume":"11","author":"M Kreuter","year":"2016","unstructured":"Kreuter M, Ehlers-Tenenbaum S, Palmowski K, Bruhwyler J, Oltmanns U, Muley T, Heussel CP, Warth A, Kolb M, Herth FJ (2016) Impact of comorbidities on mortality in patients with idiopathic pulmonary fibrosis. PLoS ONE 11(3):e0151425","journal-title":"PLoS ONE"},{"issue":"4","key":"387_CR21","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1183\/09031936.05.00021005","volume":"26","author":"V Cottin","year":"2005","unstructured":"Cottin V, Nunes H, Brillet PY, Delaval P, Devouassoux G, Tillie-Leblond I, Israel-Biet D, Court-Fortune I, Valeyre D, Cordier JF et al (2005) Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 26(4):586\u2013593","journal-title":"Eur Respir J"},{"issue":"8","key":"387_CR22","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1164\/rccm.201103-0520OC","volume":"184","author":"JK Alder","year":"2011","unstructured":"Alder JK, Guo N, Kembou F, Parry EM, Anderson CJ, Gorgy AI, Walsh MF, Sussan T, Biswal S, Mitzner W et al (2011) Telomere length is a determinant of emphysema susceptibility. Am J Respir Crit Care Med 184(8):904\u2013912","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"387_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S2213-2600(14)70124-9","volume":"2","author":"BD Stuart","year":"2014","unstructured":"Stuart BD, Lee JS, Kozlitina J, Noth I, Devine MS, Glazer CS, Torres F, Kaza V, Girod CE, Jones KD et al (2014) Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation. Lancet Respir Med 2(7):557\u2013565","journal-title":"Lancet Respir Med"},{"issue":"1","key":"387_CR24","doi-asserted-by":"publisher","first-page":"e0226084","DOI":"10.1371\/journal.pone.0226084","volume":"15","author":"L Ebner","year":"2020","unstructured":"Ebner L, Christodoulidis S, Stathopoulou T, Geiser T, Stalder O, Limacher A, Heverhagen JT, Mougiakakou SG, Christe A (2020) Meta-analysis of the radiological and clinical features of Usual Interstitial Pneumonia (UIP) and Nonspecific Interstitial Pneumonia (NSIP). PLoS ONE 15(1):e0226084","journal-title":"PLoS ONE"},{"issue":"3","key":"387_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11604-017-0713-0","volume":"36","author":"T Iwasawa","year":"2018","unstructured":"Iwasawa T, Takemura T, Ogura T (2018) Smoking-related lung abnormalities on computed tomography images: comparison with pathological findings. Jpn J Radiol 36(3):165\u2013180","journal-title":"Jpn J Radiol"},{"key":"387_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.rmed.2018.07.014","volume":"142","author":"F De Giacomi","year":"2018","unstructured":"De Giacomi F, White D, Cox CW, Moua T (2018) Evolution of diagnostic UIP computed tomography patterns in idiopathic pulmonary fibrosis: disease spectrum and implications for survival. Respir Med 142:53\u201359","journal-title":"Respir Med"},{"issue":"1","key":"387_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12931-017-0642-6","volume":"18","author":"M Karkkainen","year":"2017","unstructured":"Karkkainen M, Kettunen HP, Nurmi H, Selander T, Purokivi M, Kaarteenaho R (2017) Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis. Respir Res 18(1):160","journal-title":"Respir Res"},{"issue":"6","key":"387_CR28","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.21037\/jtd.2016.03.89","volume":"8","author":"T Kishaba","year":"2016","unstructured":"Kishaba T, Nagano H, Nei Y, Yamashiro S (2016) Clinical characteristics of idiopathic pulmonary fibrosis patients according to their smoking status. J Thorac Dis 8(6):1112\u20131120","journal-title":"J Thorac Dis"},{"issue":"5","key":"387_CR29","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/thoraxjnl-2016-209671","volume":"72","author":"R Brownell","year":"2017","unstructured":"Brownell R, Moua T, Henry TS, Elicker BM, White D, Vittinghoff E, Jones KD, Urisman A, Aravena C, Johannson KA et al (2017) The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia. Thorax 72(5):424\u2013429","journal-title":"Thorax"},{"issue":"25 Suppl","key":"387_CR30","doi-asserted-by":"publisher","first-page":"D109","DOI":"10.1016\/j.jacc.2013.10.036","volume":"62","author":"W Seeger","year":"2013","unstructured":"Seeger W, Adir Y, Barbera JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galie N, Ghio S, Gibbs S et al (2013) Pulmonary hypertension in chronic lung diseases. J Am Coll Cardiol 62(25 Suppl):D109\u2013116","journal-title":"J Am Coll Cardiol"},{"issue":"129","key":"387_CR31","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1183\/09059180.00002713","volume":"22","author":"A Caminati","year":"2013","unstructured":"Caminati A, Cassandro R, Harari S (2013) Pulmonary hypertension in chronic interstitial lung diseases. Eur Respir Rev 22(129):292\u2013301","journal-title":"Eur Respir Rev"},{"issue":"1","key":"387_CR32","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1183\/09031936.06.00037005","volume":"27","author":"G Raghu","year":"2006","unstructured":"Raghu G, Freudenberger TD, Yang S, Curtis JR, Spada C, Hayes J, Sillery JK, Pope CE 2nd, Pellegrini CA (2006) High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 27(1):136\u2013142","journal-title":"Eur Respir J"},{"issue":"3","key":"387_CR33","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1378\/chest.08-2776","volume":"136","author":"LH Lancaster","year":"2009","unstructured":"Lancaster LH, Mason WR, Parnell JA, Rice TW, Loyd JE, Milstone AP, Collard HR, Malow BA (2009) Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. Chest 136(3):772\u2013778","journal-title":"Chest"},{"issue":"2","key":"387_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.29390\/cjrt-2018-005","volume":"54","author":"AV Cardoso","year":"2018","unstructured":"Cardoso AV, Pereira N, Neves I, Santos V, Jesus JM, Melo N, Mota PC, Morais A, Drummond M (2018) Obstructive sleep apnoea in patients with fibrotic diffuse parenchymal lung disease-characterization and treatment compliance assessment. Can J Respir Ther 54(2):35\u201340","journal-title":"Can J Respir Ther"},{"issue":"7","key":"387_CR35","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.rmed.2012.03.014","volume":"106","author":"M Pillai","year":"2012","unstructured":"Pillai M, Olson AL, Huie TJ, Solomon JJ, Fernandez-Perez ER, Brown KK, Hanna P, Lee-Chiong T, Swigris JJ (2012) Obstructive sleep apnea does not promote esophageal reflux in fibrosing interstitial lung disease. Respir Med 106(7):1033\u20131039","journal-title":"Respir Med"},{"issue":"3","key":"387_CR36","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1378\/chest.13-2388","volume":"146","author":"MJ Strand","year":"2014","unstructured":"Strand MJ, Sprunger D, Cosgrove GP, Fernandez-Perez ER, Frankel SK, Huie TJ, Olson AL, Solomon J, Brown KK, Swigris JJ (2014) Pulmonary function and survival in idiopathic vs secondary usual interstitial pneumonia. Chest 146(3):775\u2013785","journal-title":"Chest"},{"issue":"1","key":"387_CR37","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12931-019-1161-4","volume":"20","author":"TM Maher","year":"2019","unstructured":"Maher TM, Strek ME (2019) Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat. Respir Res 20(1):205","journal-title":"Respir Res"},{"issue":"1","key":"387_CR38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12890-017-0468-5","volume":"17","author":"TM Maher","year":"2017","unstructured":"Maher TM, Molina-Molina M, Russell AM, Bonella F, Jouneau S, Ripamonti E, Axmann J, Vancheri C (2017) Unmet needs in the treatment of idiopathic pulmonary fibrosis-insights from patient chart review in five European countries. BMC Pulm Med 17(1):124","journal-title":"BMC Pulm Med"},{"issue":"7","key":"387_CR39","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S2213-2600(20)30168-5","volume":"8","author":"H Hatabu","year":"2020","unstructured":"Hatabu H, Hunninghake GM, Richeldi L, Brown KK, Wells AU, Remy-Jardin M, Verschakelen J, Nicholson AG, Beasley MB, Christiani DC et al (2020) Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society. Lancet Respir Med 8(7):726\u2013737","journal-title":"Lancet Respir Med"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-020-00387-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-020-00387-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-020-00387-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T23:16:01Z","timestamp":1630797361000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-020-00387-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["387"],"URL":"https:\/\/doi.org\/10.1007\/s00408-020-00387-6","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,5]]},"assertion":[{"value":"4 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}